ARENDRUP, Maiken Cavling, Sevtap ARIKAN-AKDAGLI, Karin Meinike JORGENSEN, Aleksandra BARAC, Jorg STEINMANN, Cristina TOSCANO, Valentina Arsic ARSENIJEVIC, Assunta SARTOR, Cornelia LASS-FLOERL, Axel HAMPRECHT, Tadeja MATOS, Benedict R S ROGERS, Inmaculada QUILES, Jochem BUIL, Volkan OZENCI, Robert KRAUSE, Matteo BASSETTI, Laura LOUGHLIN, Blandine DENIS, Anna GRANCINI, P Lewis WHITE, Katrien LAGROU, Birgit WILLINGER, Riina RAUTEMAA-RICHARDSON, Petr HAMAL, Beyza ENER, Tugce UNALAN-ALTINTOP, Ebru EVREN, Suleyha HILMIOGLU-POLAT, Yasemin OZ, Ozlem Koyuncu OZYURT, Faruk AYDIN, Filip RŮŽIČKA, Eelco F J MEIJER, Jean Pierre GANGNEUX, Deborah E A LOCKHART, Nina KHANNA, Clare LOGAN, Ulrike SCHARMANN, Guillaume DESOUBEAUX, Emmanuel ROILIDES, Alida Fe TALENTO, van Dijk KARIN, Philipp KOEHLER, Jon SALMANTON-GARCIA, Oliver A CORNELY and Martin HOENIGL. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM<i> Candida</i> III study. JOURNAL OF INFECTION. LONDON: W B SAUNDERS CO LTD, 2023, vol. 87, No 5, p. 428-437. ISSN 0163-4453. Available from: https://dx.doi.org/10.1016/j.jinf.2023.08.001.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM<i> Candida</i> III study
Authors ARENDRUP, Maiken Cavling, Sevtap ARIKAN-AKDAGLI, Karin Meinike JORGENSEN, Aleksandra BARAC, Jorg STEINMANN, Cristina TOSCANO, Valentina Arsic ARSENIJEVIC, Assunta SARTOR, Cornelia LASS-FLOERL, Axel HAMPRECHT, Tadeja MATOS, Benedict R S ROGERS, Inmaculada QUILES, Jochem BUIL, Volkan OZENCI, Robert KRAUSE, Matteo BASSETTI, Laura LOUGHLIN, Blandine DENIS, Anna GRANCINI, P Lewis WHITE, Katrien LAGROU, Birgit WILLINGER, Riina RAUTEMAA-RICHARDSON, Petr HAMAL, Beyza ENER, Tugce UNALAN-ALTINTOP, Ebru EVREN, Suleyha HILMIOGLU-POLAT, Yasemin OZ, Ozlem Koyuncu OZYURT, Faruk AYDIN, Filip RŮŽIČKA (203 Czech Republic, belonging to the institution), Eelco F J MEIJER, Jean Pierre GANGNEUX, Deborah E A LOCKHART, Nina KHANNA, Clare LOGAN, Ulrike SCHARMANN, Guillaume DESOUBEAUX, Emmanuel ROILIDES, Alida Fe TALENTO, van Dijk KARIN, Philipp KOEHLER, Jon SALMANTON-GARCIA, Oliver A CORNELY and Martin HOENIGL.
Edition JOURNAL OF INFECTION, LONDON, W B SAUNDERS CO LTD, 2023, 0163-4453.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30303 Infectious Diseases
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 28.200 in 2022
RIV identification code RIV/00216224:14110/23:00133411
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jinf.2023.08.001
UT WoS 001103177000001
Keywords in English Candida; C. parapsilosis; Fluconazole resistance; Echinocandin resistance; Fks1; EUCAST
Tags 14110113, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 2/2/2024 10:23.
Abstract
The objectives of this study were to assess Candida spp. distribution and antifungal resistance of candi-daemia across Europe. Isolates were collected as part of the third ECMM Candida European multicentre observational study, conducted from 01 to 07-07-2018 to 31-03-2022. Each centre (maximum number/ country determined by population size) included-10 consecutive cases. Isolates were referred to central laboratories and identified by morphology and MALDI-TOF, supplemented by ITS-sequencing when needed. EUCAST MICs were determined for five antifungals. fks sequencing was performed for echinocandin re-sistant isolates. The 399 isolates from 41 centres in 17 countries included C. albicans (47.1%), C. glabrata (22.3%), C. parapsilosis (15.0%), C. tropicalis (6.3%), C. dubliniensis and C. krusei (2.3% each) and other species (4.8%). Austria had the highest C. albicans proportion (77%), Czech Republic, France and UK the highest C. glabrata proportions (25-33%) while Italy and Turkey had the highest C. parapsilosis proportions (24-26%). All isolates were amphotericin B susceptible. Fluconazole resistance was found in 4% C. tropicalis, 12% C. glabrata (from six countries across Europe), 17% C. parapsilosis (from Greece, Italy, and Turkey) and 20% other Candida spp. Four isolates were anidulafungin and micafungin resistant/non-wild-type and five resistant to micafungin only. Three/3 and 2/5 of these were sequenced and harboured fks-alterations including a novel L657W in C. parapsilosis. The epidemiology varied among centres and countries. Acquired echinocandin resistance was rare but included differential susceptibility to anidulafungin and micafungin, and resistant C. parapsilosis. Fluconazole and voriconazole cross-resistance was common in C. glabrata and C. parapsilosis but with different geographical prevalence.(c) 2023 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PrintDisplayed: 9/8/2024 05:19